
Hair Relaxer MDL Hits 11,877 Cases as Judge Takes Over Bellwethers
The hair relaxer MDL reached 11,877 cases on July 1 — the fourth-largest MDL — after Judge Rowland took direct control of bellwether selection. Motions due Nov 16.
23 articles in this category

The hair relaxer MDL reached 11,877 cases on July 1 — the fourth-largest MDL — after Judge Rowland took direct control of bellwether selection. Motions due Nov 16.


100+ video game addiction cases are coordinated in California's JCCP 5363, with arbitration and dismissal rulings expected after the JPML denied a national MDL.

After a split first verdict, the Bard PowerPort MDL's second bellwether — a catheter fracture case — goes to trial August 18, 2026, with 3,376 cases pending.

Pfizer reached a global settlement in principle in the Depo-Provera MDL on June 15, 2026, after a record 1,739 filings in June pushed the docket past 5,500 cases.

Plaintiffs are moving to centralize Dupixent cutaneous T-cell lymphoma cases as an MDL after the FDA flagged a safety signal.


The first formula-linked infant botulism outbreak—48 cases across 19 states—is now a federal MDL in New York.



Missouri judge grants preliminary approval for Bayer's $7.25B Roundup class settlement covering 65,000 cancer claims.

158 active MDLs, 197,965 pending cases, and 95% concentrated in the top 25 dockets. A Q1 2026 mass tort landscape snapshot.

MDL-3060 adds 247 cases per month. Daubert motions due April 1 as bellwether trials approach for 2027.

The Navy has paid $530M across 2,000 offers with 90% acceptance. But 409,000 claims remain pending as bellwether trials approach.

Second-wave bellwether trials set after $495M state verdict. Federal judge schedules three new test cases through Feb 2027.

Syngenta settled the first paraquat-Parkinson's trial hours before it began. 6,400 federal cases await resolution.


HHS OCR’s Concentra settlement highlights HIPAA’s 30-day access deadline, fee limits, and what patients can do when providers delay medical records.


FDA adds meningioma warning to Depo-Provera label as MDL 3140 surpasses 2,100 cases. First bellwether trial set for December 2026.

Complete guide to Ozempic litigation including Judge Marston's landmark ruling, NAION vision loss claims, and how law firms are managing the medical record challenges with 2,190+ cases in MDL 3094.

Comprehensive overview of the social media addiction MDL developments, including the first bellwether trials, algorithmic liability theories, and what law firms need to know about representing affected families.

Latest Camp Lejeune litigation updates including court rulings, settlement progress, and how law firms are tackling the critical medical records challenge with nearly 500,000 claims filed.